|Articles|October 16, 2020
Fast and High-Resolution Reversed-Phase Separation of Synthetic Oligonucleotides
Author(s)Agilent
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Charles River Incubator Cohort to Accelerate CGT Development
2
GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale
3
New Cord Blood Stem Cell Approval Alters Biopharma Manufacturing Priorities
4
BioPharma By The Numbers: Batch Failures in Biopharma Manufacturing
5
